106 related articles for article (PubMed ID: 26496857)
1. Amplification by (-)-epigallocatechin gallate and chlorogenic acid of TNF-α-stimulated interleukin-6 synthesis in osteoblasts.
Yamamoto N; Tokuda H; Kuroyanagi G; Kainuma S; Ohguchi R; Fujita K; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
Int J Mol Med; 2015 Dec; 36(6):1707-12. PubMed ID: 26496857
[TBL] [Abstract][Full Text] [Related]
2. Amplification by (‑)‑epigallocatechin gallate of prostaglandin F2α‑stimulated synthesis of osteoprotegerin in osteoblasts.
Sakai G; Otsuka T; Fujita K; Kainuma S; Kuroyanagi G; Kawabata T; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Mol Med Rep; 2017 Nov; 16(5):6376-6381. PubMed ID: 28849144
[TBL] [Abstract][Full Text] [Related]
3. (-)-Epigallocatechin gallate amplifies interleukin-1-stimulated interleukin-6 synthesis in osteoblast-like MC3T3-E1 cells.
Kuroyanagi G; Otsuka T; Kondo A; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Tokuda H
Biochimie; 2013 Oct; 95(10):1933-8. PubMed ID: 23851196
[TBL] [Abstract][Full Text] [Related]
4. (-)-Epigallocatechin gallate reduces platelet-derived growth factor-BB-stimulated interleukin-6 synthesis in osteoblasts: suppression of SAPK/JNK.
Takai S; Matsushima-Nishiwaki R; Adachi S; Natsume H; Minamitani C; Mizutani J; Otsuka T; Tokuda H; Kozawa O
Mediators Inflamm; 2008; 2008():291808. PubMed ID: 19148296
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E
Kuroyanagi G; Tokuda H; Yamamoto N; Kainuma S; Fujita K; Ohguchi R; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Harada A; Kozawa O; Otsuka T
Prostaglandins Other Lipid Mediat; 2017 Jan; 128-129():27-33. PubMed ID: 28163121
[TBL] [Abstract][Full Text] [Related]
6. p70 S6 kinase limits tumor necrosis factor-alpha-induced interleukin-6 synthesis in osteoblast-like cells.
Minamitani C; Tokuda H; Adachi S; Matsushima-Nishiwaki R; Yamauchi J; Kato K; Natsume H; Mizutani J; Kozawa O; Otsuka T
Mol Cell Endocrinol; 2010 Feb; 315(1-2):195-200. PubMed ID: 19879324
[TBL] [Abstract][Full Text] [Related]
7. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
Tokuda H; Takai S; Matsushima-Nishiwaki R; Akamatsu S; Hanai Y; Hosoi T; Harada A; Ohta T; Kozawa O
J Cell Biochem; 2007 Apr; 100(5):1146-53. PubMed ID: 17031857
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin gallate but not chlorogenic acid upregulates osteoprotegerin synthesis through regulation of bone morphogenetic protein-4 in osteoblasts.
Fujita K; Otsuka T; Yamamoto N; Kainuma S; Ohguchi R; Kawabata T; Sakai G; Kuroyanagi G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Exp Ther Med; 2017 Jul; 14(1):417-423. PubMed ID: 28672948
[TBL] [Abstract][Full Text] [Related]
9. (-)-Epigallocatechin gallate but not chlorogenic acid suppresses EGF-stimulated migration of osteoblasts via attenuation of p38 MAPK activity.
Kawabata T; Otsuka T; Fujita K; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Int J Mol Med; 2018 Dec; 42(6):3149-3156. PubMed ID: 30272256
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
Hayashi K; Takai S; Matsushima-Nishiwaki R; Hanai Y; Kato K; Tokuda H; Kozawa O
Life Sci; 2008 May; 82(19-20):1012-7. PubMed ID: 18407296
[TBL] [Abstract][Full Text] [Related]
11. (-)-Epigallocatechin gallate inhibits thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
Kato K; Otsuka T; Adachi S; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Tokuda H
Mol Med Rep; 2011; 4(2):297-300. PubMed ID: 21468567
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin gallate inhibits basic fibroblast growth factor-stimulated interleukin-6 synthesis in osteoblasts.
Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Yamauchi J; Harada A; Hosoi T; Ohta T; Kozawa O
Horm Metab Res; 2008 Oct; 40(10):674-8. PubMed ID: 18500674
[TBL] [Abstract][Full Text] [Related]
13. Association of HSP22 with mTOR in osteoblasts: regulation of TNF-α-stimulated IL-6 synthesis.
Sakai G; Tokuda H; Yamamoto N; Matsushima-Nishiwaki R; Fujita K; Kawabata T; Kozawa O; Otsuka T
FEBS Lett; 2018 Apr; 592(7):1202-1210. PubMed ID: 29532456
[TBL] [Abstract][Full Text] [Related]
14. Wnt3a regulates tumor necrosis factor-α-stimulated interleukin-6 release in osteoblasts.
Natsume H; Tokuda H; Adachi S; Matsushima-Nishiwaki R; Kato K; Minamitani C; Otsuka T; Kozawa O
Mol Cell Endocrinol; 2011 Jan; 331(1):66-72. PubMed ID: 20732383
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin gallate inhibits TNF-α-induced PAI-1 production in vascular endothelial cells.
Cao Y; Wang D; Wang X; Zhang J; Shan Z; Teng W
J Cardiovasc Pharmacol; 2013 Nov; 62(5):452-6. PubMed ID: 23921304
[TBL] [Abstract][Full Text] [Related]
16. Role of HSP27 in tumor necrosis factor-α-stimulated interleukin-6 synthesis in osteoblasts.
Kato K; Tokuda H; Mizutani J; Adachi S; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Otsuka T
Int J Mol Med; 2011 Nov; 28(5):887-93. PubMed ID: 21811758
[TBL] [Abstract][Full Text] [Related]
17. (-)-Epigallocatechin gallate attenuates the induction of HSP27 stimulated by sphingosine 1-phosphate via suppression of phosphatidylinositol 3-kinase/Akt pathway in osteoblasts.
Natsume H; Adachi S; Takai S; Tokuda H; Matsushima-Nishiwaki R; Minamitani C; Yamauchi J; Kato K; Mizutani J; Kozawa O; Otsuka T
Int J Mol Med; 2009 Aug; 24(2):197-203. PubMed ID: 19578793
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-gallate suppresses galactose-alpha1,4-galactose-1beta,4-glucose ceramide expression in TNF-alpha stimulated human intestinal epithelial cells through inhibition of MAPKs and NF-kappaB.
Moon DO; Choi SR; Lee CM; Kim GY; Lee HJ; Park YM
J Korean Med Sci; 2005 Aug; 20(4):548-54. PubMed ID: 16100442
[TBL] [Abstract][Full Text] [Related]
19. Incretins amplify TNF-α-stimulated IL-6 synthesis in osteoblasts: Suppression of the IκB/NF-κB pathway.
Fujita K; Tokuda H; Yamamoto N; Kainuma S; Kawabata T; Sakai G; Kuroyanagi G; Matsushima-Nishiwaki R; Harada A; Kozawa O; Otsuka T
Int J Mol Med; 2017 Apr; 39(4):1053-1060. PubMed ID: 28204823
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell lines.
Porath D; Riegger C; Drewe J; Schwager J
J Pharmacol Exp Ther; 2005 Dec; 315(3):1172-80. PubMed ID: 16123309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
